Maxwell Skor Score: 40
Analyst at
Morgan Stanley
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
-9.0%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
47%
8 W / 9 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
78%
7 W / 2 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
22%
2 W / 7 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
11%
1 W / 8 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
46%
6 W / 7 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
44%
7 W / 9 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
100%
1 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Sep 03, 2026 |
Ultragenyx Pharmaceutical Inc.
RARE
|
BUY |
$18.00
Est. +22%
|
$14.72 | $16.11 |
Pending
|
$14.50
-1.5%
|
| Sep 01, 2026 |
Ascendis Pharma A/S - ADR
ASND
|
BUY |
$273.00
Est. +4%
|
$263.04 | $272.44 |
Bullseye Hit (±1%)
|
$225.60
-14.2%
|
| Aug 21, 2026 |
Ultragenyx Pharmaceutical Inc.
RARE
|
BUY |
$74.00
Est. +192%
|
$25.32 | $26.92 |
Pending
|
$14.50
-42.7%
|
| Aug 17, 2026 |
Monopar Therapeutics Inc
MNPR
|
BUY |
$130.00
Est. +12%
|
$116.18 | $121.02 |
Pending
|
$85.24
-26.6%
|
| Aug 13, 2026 |
Achieve Life Sciences Inc.
ACHV
|
BUY |
$13.00
Est. +94%
|
$6.69 | $8.55 |
Pending
|
$7.54
+12.7%
|
| Jun 25, 2026 |
Pharvaris NV
PHVS
|
BUY |
$46.00
Est. +38%
|
$33.29 | $43.25 |
Pending
|
$32.02
-3.8%
|
| Jun 11, 2026 |
CRISPR Therapeutics AG
CRSP
|
BUY |
$60.00
Est. +21%
|
$49.44 | $63.45 |
Target Met
|
$54.23
+9.7%
|
| Mar 17, 2026 |
Bicycle Therapeutics Plc - ADR
BCYC
|
BUY |
$13.00
Est. +153%
|
$5.13 | $5.41 |
Pending
|
$3.69
-28.2%
|
| Mar 13, 2026 |
Sana Biotechnology Inc
SANA
|
BUY |
$12.00
Est. +257%
|
$3.36 | $4.22 |
Pending
|
$2.95
-12.4%
|
| Feb 12, 2026 |
Ascendis Pharma A/S - ADR
ASND
|
BUY |
$256.00
Est. +16%
|
$221.49 | $281.79 |
Target Met
|
$225.60
+1.9%
|
| Jan 09, 2026 |
Monopar Therapeutics Inc
MNPR
|
BUY |
$115.00
Est. +81%
|
$63.40 | $124.42 |
Target Met
|
$85.24
+34.4%
|
| Jan 08, 2026 |
Insmed Inc
INSM
|
SELL |
$157.00
Est. +11%
|
$176.00 | $90.39 (Low) |
Target Met
|
$117.83
+33.1%
|
| Jan 08, 2026 |
Ultragenyx Pharmaceutical Inc.
RARE
|
BUY |
$50.00
Est. +107%
|
$24.20 | $36.57 |
Pending
|
$14.50
-40.1%
|
| Jan 08, 2026 |
Cytokinetics Inc
CYTK
|
BUY |
$90.00
Est. +38%
|
$65.25 | $88.31 |
Precision Hit (±3%)
|
$64.66
-0.9%
|
| Dec 04, 2025 |
Pharvaris NV
PHVS
|
BUY |
$41.00
Est. +40%
|
$29.37 | $43.25 |
Target Met
|
$32.02
+9.0%
|
| May 05, 2025 |
Bicycle Therapeutics Plc - ADR
BCYC
|
BUY |
$17.00
Est. +88%
|
$9.06 | $9.36 |
Miss
|
$3.69
-59.3%
|
| Mar 26, 2024 |
Invivyd Inc
IVVD
|
BUY |
$10.00
Est. +210%
|
$3.23 | $2.74 |
Miss
|
$0.93
-71.1%
|
Ultragenyx Pharmaceutical Inc.
RARE
Sep 03, 2026
Signal & Target
BUY
$18.00
Start Price
$14.72
Best Price (1Y)
$16.11
Current Price
$14.50
Return
-1.5%
Ascendis Pharma A/S - ADR
ASND
Sep 01, 2026
Signal & Target
BUY
$273.00
Start Price
$263.04
Best Price (1Y)
$272.44
Current Price
$225.60
Return
-14.2%
Ultragenyx Pharmaceutical Inc.
RARE
Aug 21, 2026
Signal & Target
BUY
$74.00
Start Price
$25.32
Best Price (1Y)
$26.92
Current Price
$14.50
Return
-42.7%
Monopar Therapeutics Inc
MNPR
Aug 17, 2026
Signal & Target
BUY
$130.00
Start Price
$116.18
Best Price (1Y)
$121.02
Current Price
$85.24
Return
-26.6%
Achieve Life Sciences Inc.
ACHV
Aug 13, 2026
Signal & Target
BUY
$13.00
Start Price
$6.69
Best Price (1Y)
$8.55
Current Price
$7.54
Return
+12.7%
Pharvaris NV
PHVS
Jun 25, 2026
Signal & Target
BUY
$46.00
Start Price
$33.29
Best Price (1Y)
$43.25
Current Price
$32.02
Return
-3.8%
CRISPR Therapeutics AG
CRSP
Jun 11, 2026
Signal & Target
BUY
$60.00
Start Price
$49.44
Best Price (1Y)
$63.45
Current Price
$54.23
Return
+9.7%
Bicycle Therapeutics Plc - ADR
BCYC
Mar 17, 2026
Signal & Target
BUY
$13.00
Start Price
$5.13
Best Price (1Y)
$5.41
Current Price
$3.69
Return
-28.2%
Sana Biotechnology Inc
SANA
Mar 13, 2026
Signal & Target
BUY
$12.00
Start Price
$3.36
Best Price (1Y)
$4.22
Current Price
$2.95
Return
-12.4%
Ascendis Pharma A/S - ADR
ASND
Feb 12, 2026
Signal & Target
BUY
$256.00
Start Price
$221.49
Best Price (1Y)
$281.79
Current Price
$225.60
Return
+1.9%
Monopar Therapeutics Inc
MNPR
Jan 09, 2026
Signal & Target
BUY
$115.00
Start Price
$63.40
Best Price (1Y)
$124.42
Current Price
$85.24
Return
+34.4%
Insmed Inc
INSM
Jan 08, 2026
Signal & Target
SELL
$157.00
Start Price
$176.00
Best Price (1Y)
$90.39
Current Price
$117.83
Return
+33.1%
Ultragenyx Pharmaceutical Inc.
RARE
Jan 08, 2026
Signal & Target
BUY
$50.00
Start Price
$24.20
Best Price (1Y)
$36.57
Current Price
$14.50
Return
-40.1%
Cytokinetics Inc
CYTK
Jan 08, 2026
Signal & Target
BUY
$90.00
Start Price
$65.25
Best Price (1Y)
$88.31
Current Price
$64.66
Return
-0.9%
Pharvaris NV
PHVS
Dec 04, 2025
Signal & Target
BUY
$41.00
Start Price
$29.37
Best Price (1Y)
$43.25
Current Price
$32.02
Return
+9.0%
Bicycle Therapeutics Plc - ADR
BCYC
May 05, 2025
Signal & Target
BUY
$17.00
Start Price
$9.06
Best Price (1Y)
$9.36
Current Price
$3.69
Return
-59.3%
Invivyd Inc
IVVD
Mar 26, 2024
Signal & Target
BUY
$10.00
Start Price
$3.23
Best Price (1Y)
$2.74
Current Price
$0.93
Return
-71.1%